Daré (DARE) Q4 2025 Earnings Call Summary
Daré Pharmaceuticals reported $24.7 million in cash reserves as of December 31, 2025, and raised $20.8 million through equity financing during the year. The company also secured significant non-dilutive grant funding totaling over $19 million from organizations like the Gates Foundation to support its R&D programs.
Tickers: $DARE
Topics: capital raising clinical trials pharmaceuticals R&D expenses